how often do you take cagrilintide Trial Scorecard: REDEFINE 1 and 2 Once-weekly cagrilintide for weight management

Neuroprotection Emerging Evidence Evidence Rating: Emerging (Interesting animal data, limited scope) Neurological applications show promise but require more research: Dopaminergic system protection Peripheral nerve regeneration Traumatic brain injury Alcohol-related neurological damage The GABAergic system interactions and NO modulation provide mechanistic support, but this area needs more study

BPC-157 is administered intraperitoneally at 10 g/kg or 10 ng/kg, often beginning immediately post-injury

In addition, as PAH mediates the conversion of phenylalanine (Phe) to tyrosine (Tyr), hyperphenylalaninemia (HPA) is present in all BH 4 deficiencies apart from autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (AD-GTPCHD) and sepiapterin reductase deficiency (SRD) [1, 2]

Always use a new sterile needle for each injection

When studied together, the combination is investigated for its potential to generate a more complete and organised healing response than either peptide produces independently